Because weight management is Foundayo s only approved use right now, the Bridge is effectively the one way Medicare covers it, which makes timing matter
While that decision will vary based on each companys operations and supply chain, these providers should not be ordering, prescribing, or dispensing semaglutide injection products after April 22, 2025, if those products come from a 503A compounding pharmacy, or after May 22, 2025, if those products come from a 503B outsourcing facility
I specifically started focusing on weight loss and body image around a year ago
The Weight Loss Evaluation covers a metabolic, thyroid, and insulin panel personalized to your intake
Smarter Pharmacy Benefits with AI Were using responsible artificial intelligence (AI) capabilities to supercharge pharmacy benefit experiences and drive meaningful results